Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A03BA01	ATROPINE	G	Atropine sulfate - 1mg/ml	1mg/ml	Injectable solution	702,149 L.L
M01AH05	ARTRIX 120	G	Etoricoxib - 120mg	120mg	Tablet, film coated	511,940 L.L
A03BA01	ATROPINE SULFATE RENAUDIN	G	Atropine sulfate - 1mg/ml	0.1%	Injectable solution	397,777 L.L
A03BA01	ATROPINE I.V. 0.25 MG.	G	Atropine - 0.25mg/ml	0.25mg/ml	Injectable solution	2,412,129 L.L
A03BA01	ATROPINE	G	Atropine sulfate - 0.5mg/ml	0.5mg/ml	Injectable solution	680,315 L.L
A03BA01	ATROPINE SULFATE RENAUDIN	G	Atropine sulfate - 0.5mg/ml	0.5mg	Injectable solution	385,683 L.L
A03BA01	ATROPINE SULFATEAGUETTANT	G	Atropine - 0.1mg/ml	0.1mg/ml	Injectable solution	7,805,376 L.L
C09DA06	ARKANDA PLUS 16/12.5	G	Candesartan cilexetil - 16mg, Hydrochlorothiazide - 12.5mg	32mg	Tablet	854,940 L.L
M01AX21	ART	G	Diacerein - 50mg	50mg	Capsule	1,146,298 L.L
R03BA02	AERONIDE	G	Budesonide - 400mcg	400mcg	Capsule, inhalation	2,116,552 L.L
A03BB01	ANTIPAN	G	Hyoscine N butylbromide - 20mg/ml		Injectable solution	355,798 L.L
A03BB01	ANTIPAN	G	Hyoscine N butylbromide - 20mg/ml		Injectable solution	2,557,140 L.L
L01BC01	ALEXAN	G	Cytarabine - 100mg/5ml	100mg/5ml	Injectable solution	388,370 L.L
N02BE01	ADOL	G	Paracetamol - 250mg/5ml	250mg/5ml	Suspension, alcohol free	192,169 L.L
J01DD04	AXONE 500MG IM	G	Ceftriaxone (sodium) - 500mg	500mg	Injectable powder for solution+diluent	393,746 L.L
L01BC01	ALEXAN	G	Cytarabine - 1,000mg/20ml	1,000mg/20ml	Injectable solution	2,848,946 L.L
M02AA10	ACHONID GEL	G	Ketoprofen - 2.5%	2.5%	Gel	179,179 L.L
S01CA01	API-TOBRASON	G	Dexamethasone - 1mg/ml, Tobramycin - 3mg/ml		Drops suspension	294,302 L.L
C07BB03	ATONIUM PLUS	G	Chlortalidone - 25mg, Atenolol - 50mg		Tablet	738,473 L.L
N06BA09	APO-ATOMOXETINE	G	Atomoxetine (HCl) - 60mg	60mg	Capsule	4,731,669 L.L
C07BB03	ATONIUM PLUS	G	Chlortalidone - 25mg, Atenolol - 100mg		Tablet	738,473 L.L
N06BA09	APO-ATOMOXETINE	G	Atomoxetine (HCl) - 40mg	40mg	Capsule	4,114,846 L.L
N05AH03	APO-OLANZAPINE ODT	G	Olanzapine - 5mg	5mg	Tablet, orally disintegrating	1,463,444 L.L
N06BA09	APO-ATOMOXETINE	G	Atomoxetine (HCl) - 25mg	25mg	Capsule	3,703,630 L.L
S01CA01	API-TOBRASON	G	Dexamethasone - 1mg/g, Tobramycin - 3mg/g		Ointment	243,235 L.L
L02BX03	ABLAX 250	G	Abiraterone acetate - 250mg	250mg	Tablet	L.L
C09DB01	AMLODIPINE/VALSARTAN ARROW	G	Amlodipine (besylate) - 5mg, Valsartan - 160mg		Tablet, coated	923,220 L.L
L02BX03	ABLAX 500	G	Abiraterone acetate - 500mg	500mg	Tablet	L.L
A03E	ACTICARBINE	G	Activated charcoal - 70mg, Papaverine HCl - 14mg		Tablet, coated	311,771 L.L
C09DB01	ARBITEN AM 5/160	G	Amlodipine - 5mg, Valsartan - 160mg		Caplet, film coated	857,372 L.L

...